Search
Search
About
Log in
Join
Experiences with
Estramustine
Posts
Communities
9 public posts
Filter results
Anyone with mCRPC try estramustine? Long responders to estramustine monophosphate. Report of two cases and literature review.
Long responders to
estramustine
monophosphate. Report of two cases and literature review. https://www.ncbi.nlm.nih.gov/pubmed/31475684
Long responders to
estramustine
monophosphate. Report of two cases and literature review. https://www.ncbi.nlm.nih.gov/pubmed/31475684
JLS1
in
Advanced Prostate Cancer
4 years ago
Chemotherapy with ADT & Radiotherapy for Localized High-Risk PCa.
GETUG-12 (Groupe d’Étude des Tumeurs Urogénitales)19 randomly assigned 413 patients with high-risk clinically localized disease treated with local therapy to AS (36 months) plus four cycles of adjuvant CT with docetaxel and
estramustine
or AS alone.
GETUG-12 (Groupe d’Étude des Tumeurs Urogénitales)19 randomly assigned 413 patients with high-risk clinically localized disease treated with local therapy to AS (36 months) plus four cycles of adjuvant CT with docetaxel and
estramustine
or AS alone.
pjoshea13
in
Advanced Prostate Cancer
5 years ago
My story - 16 years with metastatic prostate cancer - I’ve had just about everything
This is my story:
[u]Diagnosis [/u]
Date: November 2002 Age at diagnosis: 37 Age now: 53
[u]Treatment [/u]
1.Chemotherapy - Paclitaxel, Carboplatin,
Estramustine
- for 6 months 2.Intensity Modulated Radiotherapy - 81gy over three months 3.Zolodex - with a break in 2009 4.Zometa -
This is my story:
[u]Diagnosis [/u]
Date: November 2002 Age at diagnosis: 37 Age now: 53
[u]Treatment [/u]
1.Chemotherapy - Paclitaxel, Carboplatin,
Estramustine
- for 6 months 2.Intensity Modulated Radiotherapy - 81gy over three months 3.Zolodex - with a break in 2009 4.Zometa -
Hidden
in
Advanced Prostate Cancer
6 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Immunotherapy for Prostate Cancer: Where Do We Go From Here?—PART 1: Prostate Cancer Vaccines
rapid cytotoxic T-lymphocyte activation without the costs and cell availability limitations of cell-based approaches.[50] The first randomized phase II trial of PPVs in prostate cancer, reported in 2010, was an open-label, multicenter, crossover study comparing a four-peptide vaccine plus a low dose of
estramustine
rapid cytotoxic T-lymphocyte activation without the costs and cell availability limitations of cell-based approaches.[50] The first randomized phase II trial of PPVs in prostate cancer, reported in 2010, was an open-label, multicenter, crossover study comparing a four-peptide vaccine plus a low dose of
estramustine
JLS1
in
Advanced Prostate Cancer
6 years ago
Advice Needed Urgently
Chemo would be Ketoconazole and Doxorubicin for weeks 1, 3, and 5 and
Estramustine
and Docetaxel for weeks 2, 4, and 6. No treatments during weeks 7 and 8. Not sure if radiotherapy is included or not. There is my conundrum. I'm at a fork in the road and I don't know which way to go.
Chemo would be Ketoconazole and Doxorubicin for weeks 1, 3, and 5 and
Estramustine
and Docetaxel for weeks 2, 4, and 6. No treatments during weeks 7 and 8. Not sure if radiotherapy is included or not. There is my conundrum. I'm at a fork in the road and I don't know which way to go.
Hidden
in
Advanced Prostate Cancer
6 years ago
CRPC & Avodart [Dutasteride].
"Twenty-four (59%) patients had previously undergone chemotherapy, while 11 (27%) received docetaxel, and 24 (59%)
estramustine
." "The prostatic-specific antigen (PSA) level declined in 17 (41%) patients from the baseline value, following dutasteride treatment.
"Twenty-four (59%) patients had previously undergone chemotherapy, while 11 (27%) received docetaxel, and 24 (59%)
estramustine
." "The prostatic-specific antigen (PSA) level declined in 17 (41%) patients from the baseline value, following dutasteride treatment.
pjoshea13
in
Advanced Prostate Cancer
6 years ago
Stage 4 Treatment Success (Metastatic Prostate Cancer)
In weeks 2, 4, and 6, treatment consisted of paclitaxel 100 mg/m2 intravenously on the first day of every week in combination with
estramustine
280 mg orally 3 times a day for 7 days. 30 mg of Prednisone everyday through the three courses of chemotherapy. Last aside.
In weeks 2, 4, and 6, treatment consisted of paclitaxel 100 mg/m2 intravenously on the first day of every week in combination with
estramustine
280 mg orally 3 times a day for 7 days. 30 mg of Prednisone everyday through the three courses of chemotherapy. Last aside.
Hidden
in
Advanced Prostate Cancer
7 years ago
Non-PCa Prescription Drugs: Gout Meds.
It was the aim of this study to assess the activity of
estramustine
and colchicine, two microtubule inhibitors, in hormone-refractory prostate cancer.
It was the aim of this study to assess the activity of
estramustine
and colchicine, two microtubule inhibitors, in hormone-refractory prostate cancer.
pjoshea13
in
Advanced Prostate Cancer
8 years ago
Foods/Supplements-Vitamins: Vitamin A (Retinol, Retinoic Acid [RA], Beta Carotene)
Other trials, not considered because retinoic acid was not used as monotherapy: [B2c] (1999 - US - Phase I) 13-cis-retinoic acid, interferon alfa, and paclitaxel [B2d] (2003 - US - Phase I) 13- cis-retinoic acid, paclitaxel and interferon alpha [B2e] (2010 US - Phase II) mitoxantrone,
estramustine
Other trials, not considered because retinoic acid was not used as monotherapy: [B2c] (1999 - US - Phase I) 13-cis-retinoic acid, interferon alfa, and paclitaxel [B2d] (2003 - US - Phase I) 13- cis-retinoic acid, paclitaxel and interferon alpha [B2e] (2010 US - Phase II) mitoxantrone,
estramustine
pjoshea13
in
Advanced Prostate Cancer
8 years ago
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
9 results
Sort by
Most Relevant
Newest